Medical Xpress November 26, 2024
Luciana Constantino, FAPESP

The lack of knowledge about the benefits of human genomics for public and individual health, together with the scarcity of qualified professionals and low investment, are among the challenges that countries need to overcome in order to implement equitable public policies in the area.

To address these issues, it is essential to launch initiatives that clearly communicate the potential of genomics to different audiences and involve all interested sectors. In addition, the implementation of actions based on local priorities and international best practices is another way forward. As a result, it is hoped that the use of genomics in research and clinical practice will be expanded, promoting progress in the prevention, diagnosis and treatment of various diseases.

This whole panorama...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
A Biologist Explains The ‘Weird’ Habits Of People Who Live To 100+ Years Old
U.S. Health Care Spending Reaches $4.9 Trillion
Medicaid spending on weight loss, diabetes drugs up 500% since 2019: 5 numbers to know
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Share This Article